Buprenorphine for opioid dependence

J Pain Palliat Care Pharmacother. 2009;23(2):153-5. doi: 10.1080/15360280902900869.

Abstract

Buprenorphine is a partial mu agonist opioid that is FDA-approved to manage opioid addiction in settings outside of traditional methadone clinics. The clinical uses, pharmacokinetics, pharmacodynamics, toxicology, and management of overdoses of buprenorphine are reviewed.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Analgesics, Opioid / therapeutic use
  • Buprenorphine* / pharmacokinetics
  • Buprenorphine* / pharmacology
  • Buprenorphine* / therapeutic use
  • Drug Overdose / drug therapy
  • Humans
  • Narcotic Antagonists* / pharmacokinetics
  • Narcotic Antagonists* / pharmacology
  • Narcotic Antagonists* / therapeutic use
  • Opioid-Related Disorders / drug therapy*
  • Pain / drug therapy

Substances

  • Analgesics, Opioid
  • Narcotic Antagonists
  • Buprenorphine